Pardes Biosciences to Present at Jefferies London Healthcare Conference
CARLSBAD, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) — Pardes Biosciences, Inc. (NASDAQ: PRDS), a clinical-stage…
Month: November 2022
Albireo to Present Late Breaking Bylvay® (odevixibat) Data at AASLD 2022
– Oral late breaker with new results from positive Phase 3 ASSERT study in Alagille…
T2 Biosystems Regains Compliance with Nasdaq’s Minimum Bid Price Rule
LEXINGTON, Mass., Nov. 01, 2022 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a…
SCYNEXIS to Report Third Quarter 2022 Financial Results and Provide a Corporate Update on November 9
JERSEY CITY, N.J., Nov. 01, 2022 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology…
Quoin Pharmaceuticals to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10th
ASHBURN, Va., Nov. 01, 2022 (GLOBE NEWSWIRE) — Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company”…
SciSparc: Wellution™ Signs an Agreement with Logistics Facilities in New Jersey to Supports its Expansion to Additional e-Commerce Platforms
Agreement is expected to optimize handling and shipment processes and reduce direct sales costs TEL…
Aileron Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights
Activated multiple existing and new sites under amended Phase 1b breast cancer clinical trial protocol;…
CymaBay Announces Appointment of Charles McWherter, Ph.D. to Chief Scientific Officer and President of Research and Development
NEWARK, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage…
Phathom Pharmaceuticals Announces Placement of the Remaining $40 Million in Non-Dilutive Capital under its up to $300 Million Revenue Interest Financing Agreement
Up to $40 million committed, resulting in total financing of up to $300 million available…
Candel Therapeutics Upcoming Investor Conference Participation for November
NEEDHAM, Mass., Nov. 01, 2022 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Nasdaq: CADL), a clinical…
Paratek Pharmaceuticals to Present at the Credit Suisse 31st Annual Healthcare Conference
BOSTON, Nov. 01, 2022 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical…
CytomX Therapeutics to Report Third Quarter 2022 Financial Results on November 8, 2022
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX),…
Axial Therapeutics CEO A. Stewart Campbell to Present at Microbiome Connect: USA 2022
WOBURN, Mass., Nov. 01, 2022 (GLOBE NEWSWIRE) — Axial Therapeutics, a clinical-stage biopharmaceutical company dedicated…
St. John’s Lutheran Church Enrolls in MISO Demand Response Programs to Reduce Electricity Costs and Support Community
Church facilities support the reliability of the electric grid and reduce impact of capacity price…
Remote Enhancements Enable Customers to Offer Global Mobility and Flexible Employment Packages
Global relocation support, payment options including cryptocurrency, and unlimited PTO policies help Remote customers stand…
DEXTools App, the Trailblazing Platform in DeFi Trading, is Now Live on Android and Apple Marketplaces
New York, New York–(Newsfile Corp. – November 1, 2022) – The most promising gateway to…
Sixth Wave AMIPs(TM) Expands Detection Capabilities to Include Prevalent Foodborne Pathogens Salmonella and Listeria
Halifax, Nova Scotia–(Newsfile Corp. – November 1, 2022) – Sixth Wave Innovations Inc. (CSE: SIXW)…
Medi-Call Signs Three Distribution Agreements for Its Telehealth Services
Toronto, Ontario–(Newsfile Corp. – November 1, 2022) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB:…
ET Money Announces Investment Numbers of More than Rs.30,000 Crores on its Platform
New York, New York–(Newsfile Corp. – November 1, 2022) – ET Money, which has managed…
Mitsubishi Power and Egypt’s Damietta LNG Sign Long Term Service Agreement to Enhance Power Supply Reliability and Availability
Cairo, Egypt, Nov 1, 2022 – (JCN Newswire) – Mitsubishi Power, a power solutions brand…